Determination of platinum in tumour tissues after cisplatin therapy by electrothermal atomic absorption spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 16, Issue 2, 1997, Pages 343-348

  Milačič, Radmila ^a   Čemažar, Maja ^b   Serša, Gregor ^b  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Aqueous standards and standard addition calibration; Electrothermal atomic absorption spectrometry with Zeeman background correction; Platinum determination; Tumour tissues

Indexed keywords

CISPLATIN; PLATINUM;

ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CALIBRATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG TISSUE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE; TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; MICE; NEOPLASMS, EXPERIMENTAL; PLATINUM; REPRODUCIBILITY OF RESULTS; SPECTROPHOTOMETRY;

EID: 0342894661     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(97)00045-9     Document Type: Article

References (25)

1. C.H. Haskell (Ed.), Cancer Treatment, W.B. Saunders, Philladelphia, 1990, pp. 55-57.
2. Dewit L. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;403-426.
3. Akaboshi M., Tanaka Y., Kawai K., Akuta K., Masunaga S., Ono K. Int. J. Radiat. Biol. 66:1994;215-220.
4. Parmiani G., Rivoltini L. Curr. Opin. Oncol. 3:1991;1078-1086.
5. Serša G., Čemažar M., Miklavčič D. Cancer Res. 55:1995;3450-3455.
6. Čemažar M., Miklavčič D., Vodovnik L., Jarm T., Rudolf Z., Štabuc B., Čufer T., Serša G. Radiol. Oncol. 29:1995;229-235.
7. H.M. Pinedo, D. L. Longo, B.A. Chabner (Eds.), Cancer Chemotherapy and Biological Response Modifiers, Elsevier, Amsterdam, 1996, pp. 99-103.
8. Chu G. J. Biol. Chem. 269:1994;787-790.
9. Andrews P.A., Howell S.B. Cancer Cell. 2:1990;35-43.
10. Schramel P., Wendler I., Lustig S. Fresenius J. Anal. Chem. 353:1995;115-118.
11. Begerow J., Turfeld M., Dunemann L. J. Anal. Atom. Spectrom. 11:1996;913-916.
12. Dominici C., Alimonti A., Caroli S., Petrucci F., Castello M.A. Clin. Chim. Acta. 158:1986;207-215.
13. Lo F.B., Arai D.K., Nazar M.A. J. Anal. Toxicol. 11:1987;242-246.
14. Noto V.D., Ni D., Via L.D., Scomazzon F., Vidali M. Analyst. 120:1995;1669-1673.
15. LeRoy A.F., Wehling M.L., Sponseller H.L., Friauf W.S., Solomon R.E., Dedrick R.L. Biochem. Med. 18:1977;184-191.
16. Hopfer S.M., Yiebka L., Sunderman F.W. Jr., Sporn J.R., Greenberg B. Ann. Clin. Lab. Sci. 19:1989;389-396.
17. Smeyers-Verbeke J., Detavernier M.R., Denis L., Massart D.L. Clin. Chim. Acta. 113:1981;329-333.
18. Andrews P.A., Velury S., Mann S.C., Howell S.B. Cancer Res. 48:1988;68-73.
19. Siddik Z.H., Boxall F.E., Harrap K.R. Anal. Biochem. 163:1987;21-26.
20. Deurloo M.J.M., Kop W., van Tellingen O., Bartelink H., Begg A.C. Cancer Chemother. Pharmacol. 27:1991;347-353.
21. Vadiei K., Siddik Z.H., Khokhar A.R., Al-Baker S., Sampedro F., Perez-Soler R. Cancer Chemother. Pharmacol. 30:1992;365-369.
22. Chang M.J., Yu W.-D., Reyno L.M., Modzelewski R.A., Egorin M.J., Erkmen K., Volck D.R., Furmanski P., Johnson C.S. Cancer Res. 54:1994;5380-5386.
23. Yang L.X., Douple E.B., Wang H.J. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;641-646.
24. Einhäuser T.J., Galanski M., Keppler B.K. J. Anal. Atom. Spectrom. 11:1996;747-750.
25. Johansson A., Cavallin-Stahl E. Anti-Cancer Drugs. 7:1996;70-77.